RecruitingPhase 2NCT05888233

Allopurinol Improves Heart Function in African Americans With Resistant Hypertension

Allopurinol Improves Diastolic Function in African Americans With Resistant Hypertension


Sponsor

VA Office of Research and Development

Enrollment

50 participants

Start Date

Sep 30, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

African American adults in the United States have the highest prevalence rate of high blood pressure (hypertension) and heart failure in the world. African Americans with treatment resistant hypertension have higher levels of the enzyme - xanthine oxidase compared to Caucasians. This trial will test if administration of the xanthine oxidase inhibitor - Allopurinol (commonly used in the treatment of gout), given over a period of 8 weeks, will improve heart function, exercise ability and quality of life in African American Veterans with resistant hypertension.


Eligibility

Min Age: 18 YearsMax Age: 75 Years

Plain Language Summary

Simplified for easier understanding

This study is testing whether allopurinol — a common gout medication — can improve heart function in African American veterans who have resistant high blood pressure (blood pressure that remains high despite multiple medications). **You may be eligible if...** - You are an African American veteran - You have been diagnosed with resistant hypertension (blood pressure above 140/90 despite taking 3 or more blood pressure medications) - You live in or near Birmingham, Alabama **You may NOT be eligible if...** - You have been diagnosed with heart failure - You have chronic kidney disease with poor kidney function - You are on long-term steroid therapy - You have known coronary artery disease (blocked heart arteries) - You are already taking allopurinol - You have a pacemaker or other cardiac implant (for the MRI component) - You are claustrophobic (for the MRI component) Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGAllopurinol

Single arm of Allopurinol treatment for 300mg/daily for 4 weeks then may be increased to 600mg/daily for an additional 4 weeks.


Locations(1)

Birmingham VA Medical Center, Birmingham, AL

Birmingham, Alabama, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05888233


Related Trials